Cargando…
Erythromycin: an alternative for the management of oral mucositis?
BACKGROUND: Oral mucositis (OM) is an important acute adverse effect of anticancer therapy. This condition presents high morbidity and may lead to the suspension of anticancer therapy. MATERIAL AND METHODS: We reviewed the literature on the pathobiology of OM and the properties of erythromycin (EM),...
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medicina Oral S.L.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9445611/ https://www.ncbi.nlm.nih.gov/pubmed/35717620 http://dx.doi.org/10.4317/medoral.25439 |